The biotech industry helped draft Montana's right-to-try law, aiming to create a medical tourism hub. Now, the state relies on a privately run board to decide which experimental treatments to offer. The company behind the board created a biotech hub in a regulation-free zone on a Caribbean island. Last month, the board authorized its first treatment, raising concerns about conflicts of interest and patient value.
Related Articles
Don't miss out on breaking stories and in-depth articles.